Owing to various reasons, the demand for cell therapies is anticipated to increase over the coming years. Therefore, both therapy developers and contract service providers may need to strengthen their capabilities and expand available capacity. In this context, automation is expected to be a key enabler within the cell therapy manufacturing and contract services industry
To order this 550+ page report, which features 160+ figures and 250+ tables, please visit this - https://www.rootsanalysis.com/reports/view_document/cell-therapy-manufacturing/285.html
The USD 11 billion (by 2030) financial opportunity within the cell therapy manufacturing market has been analyzed across the following segments:
- Type of therapy
- T-cell therapies (CAR-T therapies, TCR therapies, TIL therapies)
- Dendritic cell therapies
- Tumor cell therapies
- NK cell therapies
- Stem cell therapies
- Source of cells
- Autologous
- Allogeneic
- Scale of operation
- Clinical
- Commercial
- Purpose of manufacturing
- Contract manufacturing
- In-house manufacturing
- Key geographical regions
- North America
- Europe
- Asia Pacific
- Rest of the world
The Cell Therapy Manufacturing Market (3rd Edition), 2019 - 2030 report features the following companies, which we identified to be key players in this domain:
- BioNTech Innovative Manufacturing Services
- Cell Therapies
- Cell and Gene Therapy Catapult
- Center for Cell and Gene Therapy, Baylor College of Medicine
- Centre for Cell Manufacturing Ireland, National University of Ireland
- Clinical Cell and Vaccine Production Facility, University of Pennsylvania
- Cognate BioServices
- FUJIFILM
- Guy’s and St. Thomas’ GMP Facility, Guy’s Hospital
- Hitachi Chemical
- KBI Biopharma
- Laboratory for Cell and Gene Medicine, Stanford University
- Lonza
- MaSTherCell
- MEDINET
- Molecular and Cellular Therapeutics, University of Minnesota
- Newcastle Cellular Therapies Facility, Newcastle University
- Nikon CeLL innovation
- Rayne Cell Therapy Suite, King’s College London
- Roslin Cell Therapies
- Scottish National Blood Transfusion Services Cellular Therapy Facility, Scottish Centre for Regenerative Medicine
- Sydney Cell and Gene Therapy
- WuXi Advanced Therapies
Table of Contents
- Preface
2. Executive Summary
Introduction- Market Overview
- Regulatory Landscape
- Roadmaps for Overcoming Existing Challenges
- Automation Technologies for Cell Therapy Manufacturing
- Profiles: Industry Players
- Profiles: Non-Industry Players
- Role of Non-Profit Organizations
- Partnerships
- Facility Expansions
- Capacity Analysis
- Demand Analysis
- Cost Price Analysis
- Make Versus Buy Decision Making Framework
- Market Sizing and Opportunity Analysis
- Key Insights
- SWOT Analysis
- Conclusion
- Survey Analysis
- Interview Transcripts
- Appendix 1: Tabulated Data
- Appendix 2: List of Companies and Organizations
Owing to various reasons, the demand for cell therapies is anticipated to increase over the coming years. Therefore, both therapy developers and contract service providers may need to strengthen their capabilities and expand available capacity. In this context, automation is expected to be a key enabler within the cell therapy manufacturing and contract services industry
To order this 550+ page report, which features 160+ figures and 250+ tables, please visit this - https://www.rootsanalysis.com/reports/view_document/cell-therapy-manufacturing/285.html
The USD 11 billion (by 2030) financial opportunity within the cell therapy manufacturing market has been analyzed across the following segments:
- Type of therapy
- T-cell therapies (CAR-T therapies, TCR therapies, TIL therapies)
- Dendritic cell therapies
- Tumor cell therapies
- NK cell therapies
- Stem cell therapies
- Source of cells
- Autologous
- Allogeneic
- Scale of operation
- Clinical
- Commercial
- Purpose of manufacturing
- Contract manufacturing
- In-house manufacturing
- Key geographical regions
- North America
- Europe
- Asia Pacific
- Rest of the world
The Cell Therapy Manufacturing Market (3rd Edition), 2019 - 2030 report features the following companies, which we identified to be key players in this domain:
- BioNTech Innovative Manufacturing Services
- Cell Therapies
- Cell and Gene Therapy Catapult
- Center for Cell and Gene Therapy, Baylor College of Medicine
- Centre for Cell Manufacturing Ireland, National University of Ireland
- Clinical Cell and Vaccine Production Facility, University of Pennsylvania
- Cognate BioServices
- FUJIFILM
- Guy’s and St. Thomas’ GMP Facility, Guy’s Hospital
- Hitachi Chemical
- KBI Biopharma
- Laboratory for Cell and Gene Medicine, Stanford University
- Lonza
- MaSTherCell
- MEDINET
- Molecular and Cellular Therapeutics, University of Minnesota
- Newcastle Cellular Therapies Facility, Newcastle University
- Nikon CeLL innovation
- Rayne Cell Therapy Suite, King’s College London
- Roslin Cell Therapies
- Scottish National Blood Transfusion Services Cellular Therapy Facility, Scottish Centre for Regenerative Medicine
- Sydney Cell and Gene Therapy
- WuXi Advanced Therapies
Table of Contents
- Preface
2. Executive Summary
Introduction- Market Overview
- Regulatory Landscape
- Roadmaps for Overcoming Existing Challenges
- Automation Technologies for Cell Therapy Manufacturing
- Profiles: Industry Players
- Profiles: Non-Industry Players
- Role of Non-Profit Organizations
- Partnerships
- Facility Expansions
- Capacity Analysis
- Demand Analysis
- Cost Price Analysis
- Make Versus Buy Decision Making Framework
- Market Sizing and Opportunity Analysis
- Key Insights
- SWOT Analysis
- Conclusion
- Survey Analysis
- Interview Transcripts
- Appendix 1: Tabulated Data
- Appendix 2: List of Companies and Organizations
To purchase a copy, please visit- https://www.rootsanalysis.com/reports/view_document/cell-therapy-manufacturing/285.html
Contact Details
Gaurav Chaudhary
+1 (415) 800 3415
gaurav.chaudhary@rootsanalysis.com
To purchase a copy, please visit- https://www.rootsanalysis.com/reports/view_document/cell-therapy-manufacturing/285.html
Contact Details
Gaurav Chaudhary
+1 (415) 800 3415
gaurav.chaudhary@rootsanalysis.com
